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Introduction
Cinnamon has been evaluated in clinical studies, including RCTS, for its glycemiclowering effects. The studies have been small and produced conflicting results. The objective of
this paper is to provide an updated systematic review that evaluates the relationship between
cinnamon supplementation and A1c levels among individuals with Type 2 diabetes mellitus
(T2DM).
T2DM, the most common type of diabetes, is a complex metabolic disease characterized
by high levels of blood glucose. In T2DM, there is an inability of cells to respond normally to
insulin or an inadequate production of insulin to maintain glucose control. T2DM is a global
health problem with more than 500 million prevalent cases worldwide, and the incidence is
increasing around the world1. Those with T2DM have an increased risk for several serious health
problems, including cardiovascular disease, kidney failure, blindness, limb amputation,
depression, and cognitive decline3. It is the seventh leading cause of death among adults older
than 45 years of age in the United States 2. While there is no cure for diabetes, lifestyle
modifications, drug therapy, and dietary changes are mainstays in management. Medication
therapy however poses a significant economic burden, with medical costs being twice as high
compared to those without diabetes2. Other cost-effective strategies that improve glycemic
control are worth investigating.

Research has shown that several dietary supplements have similar effects on insulin
action. Carnation, walnut, green tea, and the spice cinnamon are examples. Cinnamon, because it
is among the bioactive of these products, has garnered interest for use in hyperglycemic
conditions, such as T2DM. It has a rich history as a traditional remedy for several ailments and
has become a natural supplement of interest. Consumption of cinnamon is associated with
statistically significant reductions in fasting plasma glucose, total cholesterol, LDL-C, and
triglycerides and an increase in HDL-C levels. The review found no significant effects on A1c
levels. In a 2017 systematic review of cinnamon supplementation on blood lipid levels,
significant reductions in blood TGs and total cholesterol were observed without significant
effects on HDL-C or LDL-C. It has been suggested that cinnamon’s insulin-potentiating effects
can be attributed to its active component cinnamaldehyde6. Such hypoglycemic effects have been
investigated in in-vitro and in-vivo trials and demonstrated that cinnamaldehyde enhances
glucose uptake by activating insulin receptor kinase activity, glycogen synthesis, and
autophosphorylation of insulin receptors7.
Several clinical trials have been conducted to explore cinnamon’s efficacy on glucose
levels; however, they report conflicting results8-13. Consumption of cinnamon doses between 1 to
6 gram/daily reported reductions in fasting blood glucose (FBG) and in A1c8,10,12,15. However,
other studies showed that consumption of 1 to 1.2 gram/daily was associated with increases in
FBG and A1c11. A recent meta-analysis did not reveal any statistically significant changes in
A1c or fasting blood glucose14. Identifying safe, effective, low cost treatments for hyperglycemia
in T2DM remains important to help patients on a budget to reach glucose targets.
Methods

A systematic review of published studies reporting the effects on blood glucose of
cinnamon supplementation was conducted following the PRISMA (Preferred Reporting Items for
Systematic reviews and Meta-Analyses) guidelines. A literature search was conducted in the
following databases: PubMed and CINHAL. A search strategy was performed to include the
following combination of keywords: HbA1c, hemoglobin A1c, cinnamon, cinnamonum cassia,
type 2 diabetes, and diabetes mellitus type 2. Trials that were selected in this systematic review
were randomized control trials (RCTs) that evaluated the use of oral cinnamon supplementation
and reported data on hemoglobin A1c endpoints. Studies that included other endpoint
parameters, such as lipids and fasting plasma glucose were also included. The data specific to
HbA1c was then extracted. Study participants were limited to adult subjects. The type of
cinnamon intervention was limited to the species cinnamomum cassia. Type 2 diabetics,
excluding those taking insulin, of either gender or age were included. The formulation and
dosage of cinnamon intervention was not restricted. The search included countries outside of the
United States.
Results
A total of 5 RCTs met the inclusion criteria and were included in the systematic review.
These 5 RCTs together considered a total of 313 patients who followed the study for a range of
40 to 90 days. All the RCTs administered cinnamon powder, specifically cinnamomum cassia,
with the dose ranging from 1 to 6 grams per day. The characteristics of the study participants,
study characteristics used in RCTs, and results of the selected studies are reported in Table 1,
Table 2, and Table 3, respectively.
The results of the first human RCT reported that the addition of 1, 3, or 6 g of cinnamon
led to significant decreases in serum glucose levels after 40 days. All three doses of cinnamon

reduced the mean fasting plasma glucose (FPG) ranging from 18 to 29% (Table 3). The response
to all three levels of cinnamon was similar suggesting that there is no evident dose response. The
second RCT failed to detect any significant effect in A1c or serum glucose levels after addition
of 1 g of cinnamon daily for 90 days (Table 3). The third RCT reported that a daily intake of 2 g
of cinnamon for 12 weeks showed significant reduction in A1c. The fourth RCT suggested that
intake of 1.5 g of cinnamon per day was associated with reduction in A1c levels (Table 3). The
fifth RCT was unable to recommend cinnamon for the treatment of T2DM as it failed to improve
A1c levels (Table 3).
Table 1. Characteristics of Participants in included RCTs of systematic review
Variable

Khan et al.

Blevins et al.

Akilen et al.

Tangvarasittichai

Talaei et al.

et al.
Treatment Placebo/Cinnamon Placebo/Cinnamon Placebo/Cinnamon Placebo/Cinnamon Placebo/Cinnamon
N

30

28

28

50

19

30

29

30

49

20

Gender

M&W

M&W

M&W

M&W

M&W

Time since

6.73 ± 2.32

N/A

5.84 ± 4.23

8.14 ± 2.75

N/A

diagnosis

7.10 ± 3.29

5.76 ± 4.93

9.04 ± 4.76

of DM (y)
Mean Age

52.0 ± 6.87

58.0

54.43 ± 12.53

56.9 ± 1.2

56.29 ± 9.49

(y)

52.0 ± 5.85

63.6

54.90 ± 10.14

57.2 ± 1.11

57.61 ± 8.70

Mean BMI

N/A

32.0 ± 1.5

32.13 ± 8.31

24.7

29.02 ± 5.53

32.5 ± 1.7

33.36 ± 4.20

24.7

26.41± 3.06

Table 2. Summary of methodology in included RCTs of systematic review

Study

Year

Location

Study Type

Type of

Dosage of

Cinnamon

Cinnamon

(Treatment)

(grams)

C. cassia

Type of Placebo

Duration

(Control)

(day)

1, 3, 6

Unknown

40

C. cassia

1

Wheat flour

90

C. cassia

2

Starch

84

C. cassia

1.5

Unknown

60

C. cassia

3

RCT,
Khan et al.

2003

Pakistan
double-blind
RCT,
placebo-

Blevins et al.

2007

USA
controlled,
double-blind
RCT,

Akilen et al.

2010

England
double-blind

Tangvarasittichai et

RCT,
2015

Thailand

al.

double-blind
RCT,

Talaei et al.

2017

Iran

Microcrystalline

double-blind

56
cellulose

Table 3. Results of included RCTs in systematic review
Study

Khan et al.

Baseline a1c

Post-trial a1c

Baseline a1c

Post-trial a1c

(Treatment

(treatment)

(Control)

(control)

8.9 ± 2.7

7.1 ± 2.6

12.2 ± 2.3

9.4 ± 2.3

7.2 ± 0.3

7.4 ± 0.4

7.1 ± 0.2

7.2 ± 0.4

8.2 ± 1.1

7.86 ± 1.42

8.55 ± 1.8

8.68 ± 1.83

2003
Blevins et al.
2007
Akilen et al.

2010
Tangvarasittichai et

8.0

7.6

7.7

8.0

10.04 ± 1.30

10.11 ± 1.49

10.31 ± 1.86

10.30 1.70

al.
2015
Talaei et al.
2017

Discussion
In this systematic review of studies assessing glycemic control, consumption of cinnamon,
specifically the cinnamonum cassia formulation, of at least 1 gram daily may reduce HbA1c in
T2DM patients. When comparing changes in serum glucose to the dosage of supplementation
given, as in Khan12, a decrease in serum glucose was observed across all three groups. This
suggests that there is no significant dose response associated with degree of glycemic control. In
general, cinnamon was well-tolerated, and no side effects were documented. A systematic review
by Namazi et al17 showed that cinnamon can reduce levels of glucose in serum with no changes
in other glycemic parameters. However, it was stated that the studies’ high heterogeneity should
be interpreted lightly.
A limitation of this analysis is in the quality of the interventions performed. Multiple
characteristics of the 5 RCTs including gender, age, ethnicity, years of diagnosis of T2DM,
baseline HbA1c, and baseline BMI were all varied suggesting a degree of heterogeneity
contributing to the results. Other factors such as diet at baseline or during the experimental
period were not reported which may have also contributed to the heterogeneity of the results.
Another limitation is the lack of documentation of compliance to supplementation by pill counts
was only achieved by one study.

To conclude, the data suggests that cinnamon supplementation, when used as an adjunct to
diabetic management, may provide some lowering effects on HbA1c. However, it is not
recommended as a replacement for hypoglycemic medications, exercise, or proper diet. Given
the increasing prevalence of T2DM and the economics of our pharmaceutical system, it is within
reason to consider safe adjuncts, especially if it can help improve glycemic control. For diabetics
on a tight budget, cinnamon may serve as a cost-effective adjunct to standard therapy to help
patients reach glucose targets and attain their goal HbA1c level.
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